What’s Going On With On Holding Stock Tuesday? – On Holding (NYSE:ONON)
On Holding Earnings Snapshot The company reported record first-quarter net sales of 831.9 million Swiss francs, up 14.5%…
What’s Going On With C4 Therapeutics Stock Thursday? – C4 Therapeutics (NASDAQ:CCCC)
C4 Therapeutics Inc. (NASDAQ:CCCC) shares rose in Thursday’s session after climbing as high as $3.66 in premarket trading.…
Roche’s Obesity Drug Helps Almost 87% People Lose At Least 10% Weight – Roche Holding (OTC:RHHBY)
CT-388 is an investigational once-weekly subcutaneous injectable, dual GLP-1/GIP receptor agonist being developed for the treatment of obesity,…
12 Health Care Stocks Moving In Thursday’s After-Market Session – ALPS Group (NASDAQ:ALPS), Co-Diagnostics (NASDAQ:CODX)
Gainers iSpecimen (NASDAQ:ISPC) shares moved upwards by 70.7% to $0.38 during Thursday’s after-market session. The market value of…
What’s Going On With Olema Pharmaceuticals Stock On Wednesday? – Olema Pharmaceuticals (NASDAQ:OLMA)
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) stock plunged on Monday as the company navigates recent developments in its clinical trials.…
Roche’s Breast Cancer Drug Falls Short In Phase 3 Study – Roche Holding (OTC:RHHBY)
Roche Holdings AG (OTC:RHHBY) on Monday shared results from the phase 3 persevERA Breast Cancer study of giredestrant…
Roche’s Obesity Drug Shows Promise But Trails GLP-1 Giants Novo Nordisk, Eli Lilly – Roche Holding (OTC:RHHBY)
Genentech on Thursday shared topline results from the Phase 2 ZUPREME-1 trial evaluating petrelintide versus placebo in 493…
Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement – Novartis (NYSE:NVS)
Novartis AG (NYSE:NVS) has reportedly reached a confidential settlement with the family of Henrietta Lacks, decades after her…
Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push – Roche Holding (OTC:RHHBY)
On Thursday, Roche Holdings AG (OTC:RHHBY) agreed to acquire 89bio, Inc. (NASDAQ:ETNB) for $2.4 billion. 89Bio is a…
Why Is Olema Pharmaceuticals Stock Soaring Today? – Olema Pharmaceuticals (NASDAQ:OLMA), Roche Holding (OTC:RHHBY)
The trial evaluated giredestrant as an adjuvant (refers to treatments given after the main treatment) endocrine treatment for…
Valuation Disagreement Sinks Rio And Glencore Mega-Merger – Glencore (OTC:GLCNF), Rio Tinto (NYSE:RIO)
For more than a decade, billionaire Ivan Glasenberg chased the White Whale of mining M&A, a merger between…
Roche Sees Steady 2026 Growth As Key Drugs Post Double-Digit Gains – Roche Holding (OTC:RHHBY)
Roche Holdings AG (OTC:RHHBY) reported fiscal 2025 sales of 61.5 billion Swiss Francs (around $76.96 billion), up 7%…